| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.48 | 0.005 |